Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2022)

Vivos Therapeutics' Interest Coverage Ratio history spans 3 years, with the latest figure at 150.19 for Q3 2022.

  • Quarterly results put Interest Coverage Ratio at 150.19 for Q3 2022, up 75.44% from a year ago — trailing twelve months through Jun 2023 was 583.11 (down 393.59% YoY), and the annual figure for FY2021 was 304.36, down 142.68%.
  • Interest Coverage Ratio for Q3 2022 was 150.19 at Vivos Therapeutics, up from 188.22 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 2177.5 in Q4 2021 to a low of 4061.0 in Q2 2021.
  • The 3-year median for Interest Coverage Ratio is 174.71 (2022), against an average of 638.26.
  • Peak annual rise in Interest Coverage Ratio hit 700.09% in 2021, while the deepest fall reached 5722.38% in 2021.
  • Year by year, Interest Coverage Ratio stood at 362.86 in 2020, then surged by 700.09% to 2177.5 in 2021, then plummeted by 106.9% to 150.19 in 2022.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 150.19, 188.22, and 174.71 for Q3 2022, Q2 2022, and Q1 2022 respectively.